{
  "id": 14376294,
  "title": "Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo",
  "url": "https://urgent.news/2026/10/14/biocon-clears-patent-hurdle-for-breast-cancer-biosimilar-pebrilzo",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-14T05:08:34.000Z",
  "source": {
    "name": "Business Standard IN",
    "slug": "business-standard-in",
    "url": "https://www.business-standard.com/companies/news/biocon-pebrilzo-pertuzumab-biosimilar-genentech-patent-settlement-126101400326_1.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}